Intervet / Schering Plough Animal Health has launched Leventa, an easily administered once daily, liquid treatment for canine hypothyroidism.
Leventa is a low volume liquid formulation of levothyroxine sodium which provides the thyroxine needed by dogs with hypothyroidism. The company says it is readily accepted.
Until now, thyroxine has only been available in a tablet format. Leventa comes in a single presentation 30 ml bottle with a dosing syringe suitable for all weights of dogs, allowing straightforward storage and stock control.
Leventa enables accurate dosing and easy dose titration. The ready-to-dispense pack avoids time-consuming tablet dispensing and handling of medications.
In addition to the practical compliance benefits of the liquid format, Intervet / Schering Plough says Leventa also offers excellent bio-availability1. In trials, 79% of dogs stabilised on the once daily starting dose of 20g/kg avoiding lengthy stabilisation2.
Vicki Winslet, Veterinary Advisor at Intervet / Schering Plough said: "One of the greatest challenges faced by vets for effective treatment is owner compliance. Leventa overcomes this issue with a simple syringe dose replacing the need for tablets of varying sizes and quantities."
One of the most common endocrine disorders in dogs but difficult to diagnose, hypothyroidism can lead to a variety of issues including weight gain, lethargy and coat problems (including dullness, loss or thinning). It can also cause insulin resistance in diabetic dogs.
The launch of Leventa further extends Intervet / Schering Plough's endocrine portfolio which includes Caninsulin, developed for the treatment of diabetes in small animals and Vidalta, a once daily treatment for hyperthyroidism in cats which is already proving extremely popular with the profession.
For further information, please contact your Intervet/Schering-Plough account manager or telephone the company's Veterinary Support Group on 01908 685685.
1. Le Traon G, Burgaud S, Horspool LJ. (2008) Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium. J Vet Pharmacol Ther 31:95-101.2. Gommeren K, Benchekroun G, Brennan S.F, Burgaud S, Daminet S, Horspool L.J.I, Le Traon G, Rosenberg D, Mooney C.T (2008) A novel L-thyroxine solution is a safe and effective once daily treatment for canine hypothyroidism. In:Proceedings BSAVA congress 2008 , 3-6 April Birmingham, UK pp487-488
The RCVS Veterinary Nurses Council has decided that the College should cease being an awarding body next year, which means it will no longer offer the vocational Level 3 Diploma in Veterinary Nursing.
The College says it will ensure that the Diploma continues to be available by transferring the intellectual property associated with the qualification, such as the question banks and systems, to another larger awarding body, in a move which is likely to take effect for the beginning of the 2012 academic year.
According to the College, this decision reflects recent changes in the regulatory Conditions of Approval for awarding bodies, which it would have been hard for the College to meet while continuing to offer the Diploma cost-effectively. The changes mainly relate to potential conflicts of interest between the College's primary role, as professional regulator that safeguards standards within the veterinary professions, and its role as an awarding body. The standards-setting role includes the regulation of education and training leading to the veterinary and VN registers, and it was felt that the College could no longer exercise this role effectively if it was also an awarding organisation, as it might be suspected of treating its internal qualifications more favourably, or of obstructing competitors.
Although the College says this has not been a problem in the past, the rules are now more stringent, and the costs of setting up a fully independent awarding body would be prohibitive.
The market for the Diploma is also likely to fragment in the future, with three other awarding bodies expressing an interest in offering a Level 3 Diploma. Any reduction in the number of students taking the RCVS Level 3 Diploma would further push up the costs, potentially making the RCVS Awarding Body unviable. A larger awarding body can take advantage of economies of scale across a range of awards in a way that the RCVS cannot.
Colonel Neil Smith, Chairman of the RCVS Awarding Body Board said: "The RCVS has been offering vocational qualifications since 1998 and the decision to cease being an awarding body has not been taken lightly.
"We have taken this decision in order to focus on our core responsibilities of professional regulation and standard setting. However, we remain committed to maintaining the Diploma, which has been carefully developed by the RCVS and the profession. This move ensures that it will stay in safe hands."
The name of the awarding body to which the qualification will be transferred has not yet been announced because the process is not complete. However, the College says it felt it was important to give those involved with the delivery of training as much notice as possible of the change. More information, and the change-over plan, will be released in due course.
Libby Earle, RCVS Head of Veterinary Nursing said: "Our priority will be effecting a smooth transfer for students, Colleges and training practices, and we are confident that the impact of the change will be minimal. Furthermore, it will be a condition of the transfer that the veterinary profession continues to have a say in the future development of the qualification."
Those students still in the process of completing the old NVQ qualifications, the accreditation of which is due to run out in 2013, will continue to be serviced by the RCVS.
As the professional regulator, the College will continue to issue RCVS certificates and badges to those who have successfully completed a registerable qualification - such as an approved vocational qualification run by another awarding body, or an RCVS-recognised veterinary nursing degree.
The Advanced Diploma in Veterinary Nursing will be unaffected by the change as the qualification is awarded by the College under its Royal Charter powers.
Set up in 2012, the programme was developed to raise the standards of care and welfare of cats in the veterinary clinic, and to provide veterinary surgeons with practical solutions to problems that they face when dealing with their feline patients. The programme is also designed to boost business by strengthening the bond between the clinic and its feline clients.
Four years later, with 732 practices accredited worldwide (369 in the UK) and a further 1,000 US practices accredited under the American Association of Feline Practitioners scheme licensed from ISFM, the programme has become a well-recognised global standard in feline veterinary care. Last October, it was the winner of the 2016 Veterinary Record Innovation Award.
ISFM says it has now signed six new commercial partners for the scheme: Boehringer Ingelheim, Ceva Animal Health, Elanco, Idexx Laboratories, Merial and Royal Canin, and will be working with these partners to expand the programme further.
Dr Andy Sparkes, Veterinary Director of International Cat Care, ISFM’s parent charity, said: We are delighted to see how many clinics around the world have focused on becoming cat friendly and we can only expect this to grow again in 2017 with our new partners on board. We are looking forward to a very cat friendly 2017!"
Clinics interested in joining the scheme should visit: www.catfriendlyclinic.org for further information, including an extensive library of photographs from already-accredited clinics to provide inspiration and ideas.
The speakers are:
Dr Lappin said: “There are a number of significant changes in the management of SARS-CoV-2 that impact companion animal medicine and our staff members since our first webinar. I believe the information to be presented will be extremely valuable in helping your veterinary team continue to successfully navigate this pandemic.”
David Sutton, Global Technical Director at webinar sponsors MSD Animal Health, said “COVID-19 has presented an extraordinary challenge to the global community. MSD Animal Health is proud to support WSAVA in providing quality education to veterinary professionals who continue to go above and beyond in the care of companion animals during the pandemic.”
To register for the webinar, visit: http://bit.ly/wsavawebinar-covd19-registration
The company initiated the recall after identifying a potential for the sterility/stability of the product to be compromised due to a crimping problem of the aluminium cap.
The recall is for the 100 ml bottles of the following batch only:
Batch No.0C3829 Expiry Date 03/12/2022
Vetoquinol UK Ltd is contacting veterinary surgeons and veterinary wholesalers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact the Customer Services Department on +44 1280 814500 Option 1 or email: UK_office@vetoquinol.com.
LacriProtect is designed to increase the depth of the tear film in the management of dry eye, during anaesthesia, or in case of irritation.
It contains a carbomer-based formula in individual, resealable single-use pipettes, so that each application is hygienic and free from cross-contamination.
This, says Samaxia, is particularly useful in clinical settings.
Lacri+ contains 0.4% cross-linked sodium hyaluronate and urea, and is designed to hydrate, lubricate and protect the ocular surface.
It comes in a multi-dispense bottle with a tip-seal mechanism and multilayer filtration to ensure sterility and give a shelf life of three months after opening.
https://www.samaxia.com
606 veterinary professionals took part in the research, mostly Practice Managers (34%), Head Nurses (23%) Head Vets (22%) and Administrators (9%)
Of all the respondents, which included those newly-promoted, early career, middle management, senior management and principal leaders, 33% of respondents described their competence as ‘intermediate’, 47% as intermediate, 18% as 'advanced' and only 2% as ‘expert’.
The VMG says its report raises fresh concerns about the preparedness of those tasked with steering veterinary teams through an increasingly complex and demanding landscape.
Rebecca Robinson MRCVS (pictured), incoming VMG President, said: “This year’s report again highlights the urgent need to equip both current and future leaders with the skills and support they need to thrive.
"While there are encouraging signs of progress, we must act with greater urgency as a profession to embed leadership development at every level - especially for those stepping into leadership roles for the first time."
“We encourage all members of the veterinary team to invest in developing their communication and influencing skills well before they take on leadership roles.
"Gaining experience in these areas early on will better prepare them for the demands of leadership and empower them to take charge of their career journeys.
“We also call on employers to make leadership development a priority."
The VMG offers a range of Institute of Leadership and Management-accredited qualifications – the Award, Certificate and Diploma in Veterinary Leadership and Management.
https://vetmg.com/qualifications/cvlm/
The Disciplinary Committee of the Royal College of Veterinary Surgeons has refused an application for restoration to the RCVS Register from a Kent-based former veterinary surgeon struck off in 1994 for disregarding basic hygiene at his professional premises and failing to properly maintain a Controlled Drugs Register or patient records.
In June 1994, the Committee found that Mr Warwick John Seymour-Hamilton, at that time the only veterinary surgeon practising at premises at 9 Orchard Grove, Orpington, Kent, was guilty of disgraceful professional conduct and should have his name removed from the Register. The state and condition of the premises were found to be such as to risk the health and welfare of animals taken to the premises, and bring the profession into disrepute. An application made by Mr Seymour-Hamilton for restoration made in 1995 was refused.
At a restoration hearing on 18 June 2010, Mr Seymour-Hamilton told the Committee that he sought restoration to the Register because he wished to further his research work into plants with potential medicinal properties. Restoration, he said, would improve his professional status by giving him more credibility, particularly in terms of recognition by the medical and veterinary professions.
Mr Seymour-Hamilton said that he had no intention of returning to clinical practice immediately, and neither the Committee nor the College had heard of any adverse conduct by the applicant since his removal.
However, Caroline Freedman, Chairman of the Disciplinary Committee, noted that if Mr Seymour-Hamilton were to be restored, the Committee would have no power to prevent him from returning to general practice.
Mr Seymour-Hamilton's response to questioning by the Committee raised a number of concerns with respect to the future welfare of animals should restoration be granted. He told the Committee that he had not undertaken any relevant Continuing Professional Development in the past 15 years, and said he lacked knowledge of current relevant legislation, for example, the Animals (Scientific Procedures) Act 1986 and basic 'Cascade' prescribing requirements. He also said that he had not read the RCVS Guide to Professional Conduct in the past 15 years and that it would not be satisfactory for him immediately to return to general practice.
Ms Freedman said: "If the Committee were to reinstate the Applicant to the Register, it would have to be satisfied that he is competent and safe to practise immediately. The Committee has an obligation to protect the public and animal welfare and cannot simply accept his assurances that he would take steps to rectify his self-confessed shortcomings at some point in the future."
Having taken all the evidence presented into account, the Committee was not satisfied that Mr Seymour-Hamilton was fit to be restored to the Register and dismissed his application.
Companion Care Vets has been named as one of The Sunday Times 100 Best Companies To Work For, the first veterinary organisation to receive the accolade.
Companion Care, which has 90 surgeries across the UK (the majority within Pets at Home stores) launched its joint venture partner model in 2001. The group received a "first class" one-star status from The Sunday Times, and was ranked at number 69 overall, a position determined by employee views, staff policies, processes and services.
Best Companies Accreditation is based around employee engagement and listed companies are noted for "excelling in every area throughout the workplace." Particularly recognised is an organisation's commitment to its most important assets - its workforce.
Jane Balmain, Managing Director of Companion Care Vets said: "We value every member of our team who have all worked tirelessly over the past 11 years to help our expansion into the market leader we are today. Without the commitment and expertise of every person within the organisation this would not have been possible and for us to receive this recognition, and on our first try, is outstanding."
Jane added: "To be the first veterinary organisation to receive Best Companies Accreditation is an honour and we will strive to continue to provide an exceptional working environment for our teams."
As part of the survey process 79% of Companion Care Vets' employees said their jobs are good for personal growth, 76% felt their jobs were secure and a fantastic 81% said colleagues are committed to taking care of each other.
With 109 Joint Veterinary Partners and a further 867 employees in the group, Companion Care Vets is one of the largest veterinary employers in the UK. The company plans to have 200 surgeries in place by 2015 which will create a host of career opportunities for vets and veterinary support teams around the UK.
The Royal College has announced that a Legislative Reform Order (LRO) to reconstitute its disciplinary committees separately from its Council has been signed by Defra Minister David Heath, and will come into force on 6 April 2013.
The LRO will amend Part I of Schedule 2 of the Veterinary Surgeons Act 1966 (VSA) and require that the RCVS Preliminary Investigation and Disciplinary Committees are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently.
This will ensure that the same group of people is not responsible for setting the rules, investigating complaints and adjudication, and will bring lay people formally into the Preliminary Investigation Committee.
The LRO will also allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings, reducing the workload on the individual Committee members whose primary appointment is to RCVS Council.
The RCVS has been working on the LRO with Department of Environment, Food and Rural Affairs (Defra) officials since late 2010, and the Order was based on consultations undertaken by the RCVS and Defra.
According to the College, the Order was commended at every stage of Parliamentary scrutiny as an effective means to address the single biggest deficit of the VSA and to improve how the RCVS regulates the profession. During debate in Grand Committee of the House of Lords on 10 January, the RCVS received considerable praise for its strenuous efforts to modernise under the constraints of the present legislation, and the LRO received unanimous support.
Following the Order coming into force, the first external members will join the Disciplinary and Preliminary Investigation Committees from July 2013. After a two-year transition period, members of the RCVS Council will become ineligible for membership of these committees. Information about how to apply to join these committees will be available shortly.
President Jacqui Molyneux said: "I am delighted the LRO has been made and I am immensely thankful for the hard work of the Defra team and my colleagues in the College. The LRO is the single biggest reform to the regulation of veterinary surgeons since the 1966 Act, and it will bring the RCVS in line with regulatory best practice and improve the perception of the independence of the RCVS disciplinary processes."
The Elekta Infinity linear accelerator is the only one of its kind for pets in England.
CVS says it allowing the centre to offer “cutting edge” image-guided radiation treatments for cancer in cats and dogs – meaning fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital is now at the forefront of cancer care in animals.
"We have invested in this state-of-the-art technology to bring cancer treatment in pets to the next level.
“Our unique linear accelerator allows us to offer advanced image-guided treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage of these treatments is that high dose rates of focused beams are delivered with high precision over a shortened treatment course, with greater safety for the patient’s healthy tissue.
“It has now drawn many tumours into the realm of treatability, it is improving the quality of life for patients, and it is making it easier for owners to manage their pet’s treatment and aftercare.”
Still, the installation of the linear accelerator will probably have cost the same again, and then you've got the running costs.
That's not an inconsiderable cost per patient.
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
To help veterinary practices engage with pet owners and help them understand the importance of eye health, TVM has produced a range of free educational materials including waiting room displays, informative web pages and social media packs.
The company has also published a page of information at www.tvm-uk.com/eyehealth – where pet owners can find out more about eye problems, how to spot them and learn what can be done about them.
Emma Hancox MRCVS, Veterinary Advisor at TVM said: "It can be easy for owners to miss the signs of problems with their pet’s eyes, but they can be extremely distressing for animals and be a sign of conditions ranging from cataracts and glaucoma through to conjunctivitis - all of which can be painful, and in the worst-case scenario, lead to blindness.
"We hope that National Pet Eye Health Awareness Week will help practices assist owners in understanding the importance of eye health and prevent more serious conditions occurring."
To request your board kit and pet owner leaflets, and download your free social media pack, visit www.tvm-uk.com/eyehealth or contact your Territory Manager.
The research was carried out by scientists from Wisdom Panel, a pet DNA testing company that is part of Mars Petcare’s Science & Diagnostics division.
The discovery was made by analysing clinical data from Banfield Pet Hospital paired with DNA data from Wisdom Panel.
The researcher say estimates suggest canine atopic dermatitis affects up to 10-30% of dogs, and that these findings could lead to more targeted solutions in the future.
In addition, identification of the SLAMF1 variant presents the opportunity for breeders to breed toward dogs with a lower risk of atopic dermatitis.
Jimmy Barr, DVM, DACVECC, Chief Medical Officer for Mars Petcare’s Science & Diagnostics division said: “This finding could have a real impact on dog health
"While atopy has long been suspected to have a genetic component, this is the first time the SLAMF1 gene has been convincingly linked to this debilitating skin condition.
"This knowledge will help identify dogs at risk and could lead to new therapies and more informed dog breeding practices.”
Wisdom Panel has developed a DNA test that will be offered in partnership with Canine Genetic Testing at the Department of Veterinary Medicine, University of Cambridge so breeders can make informed decisions to reduce the frequency of atopic dermatitis while maintaining genetic diversity.
Reference
https://www.cagt.co.uk
Photo: https://depositphotos.com
The British Veterinary Association's Council has agreed unanimously to reject Animal Health's proposal to base fees for Official Veterinarians (OVs) on the available budget instead of an hourly rate, which the BVA negotiating team has been pushing for for some time.
The BVA team argued consistently for a professional fee for professional work and based its demands on the independent ADAS report and SPVS fees surveys. Animal Health proposed a matrix for TB testing fees based on the number of animals tested and the distance travelled and said that there would be no further discussion on an appropriate professional fee due to budget constraints. The BVA Council felt strongly that it could not accept a proposal that was based on a finite budget and did not respect the need for a professional fee for veterinary work.
BVA President Bill Reilly said: "While we understand the budget squeeze on Animal Health, BVA Council has taken a principled stand that vets should be paid a professional fee for a professional service, not a fee based on the available budget.
"With the launch of the draft Animal Health Bill last Monday we call on the Government to consider the central role OVs play in this new disease control set up and to provide sufficient funding. Launching the draft Bill, Defra's Minister of State spoke of partnership. OVs are such a partner, professionals integral to the disease prevention and control mechanisms. The country has a major disease problem in TB which requires professionals to ensure control and protection of the public and animals alike.
"Let me clarify that Animal Health will not be negotiating with individual vets - they will simply be paying at the same rate in 2010/11 as in 2009/10 and no guarantee that the budget will not be reduced in the future. Each individual veterinary practice will need to decide whether or not they wish to continue TB testing or other OV work."
The BVA and BCVA are advising members that they will need to take a decision in their own practice on whether or not it is financially viable for them to continue OV work.
The Royal Veterinary College has opened a new specialist ophthalmologist service at the Queen Mother Hospital for Animals (QMHA) in Hertfordshire.
According to the College, the service is equipped with the most up-to-date and state-of-the-art equipment available and will also benefit from the on-hand support of leading edge veterinary care at Europe's largest small animal hospital.
The RVC says all ophthalmology cases will be supported by dedicated anesthesiologists, whilst on an individual case basis the ophthalmologists will draw upon the expertise of specialists in imaging, oncology, neurology, emergency and critical care, internal medicine, dermatology, soft tissue and orthopedic surgery.
The following services will be available to all species on referral:
Rick F. Sanchez, who heads up the new service, holds a Diploma from the European College of Veterinary Ophthalmologists (DipECVO) and is currently the only Ophthalmology Diploma holder working in a UK university. In his new role Rick will be sharing his expertise gained from the 3 years intensive specialist training and 7 years in dedicated specialty practice with both undergraduate and postgraduate students at the college in a teaching role alongside his clinical and research responsibilities.
Rick said: "Returning to academia has been the realization of a long held professional dream and to do so by becoming part of the Royal Veterinary College has been a privilege and an honour. The superb team of specialists and dedicated nurses already established at the RVC creates a perfect environment to exercise clinical excellence and offer our animal patients the very best care we strive to provide as specialists.
"In addition, I see the creation of the new Ophthalmology Service as the final piece of the puzzle within the wide array of clinical expertise offered at QMHA. In my opinion it is this wide array of expertise that makes the QMHA at the RVC a leading centre for clinical, teaching and research excellence in veterinary medicine in the UK."
For more information please visit: http://www.rvc.ac.uk/QMH/Specialities/Ophthalmology.cfm
A Market Harborough-based practice - Town & Country Veterinary Centre - has announced that it is entering a team into a 10km obstacle course race so gruelling it is called 'The Suffering'.
The Suffering takes place in the grounds of Rockingham Castle, Leicestershire, on Saturday 12 March 2016. It includes more than 25 water, mud and rope-based obstacles.
The Town & Country team, which includes vets, nurses, students and receptionists, hopes to raise £1,000 for Vets for Change, which is fundraising to vaccinate dogs in Africa against rabies.
Michael Lander MRCVS said: "We are big supporters of the work of Vets for Change which is currently fundraising for its next mass vaccination programme in South Africa. The race does sound gruelling and I have done no training as yet although some of my colleagues have been hitting the gym for the past couple of months. We will all pull together on the big day and getting everyone round the course is our goal.
"We'd be very grateful for donations to help us reach our target for Vets for Change which does such fantastic work and have set up a just giving page at https://crowdfunding.justgiving.com/townandcountry-veterinarycentre."
The team members are: Sarah Kay Robinson (Receptionist), Chloe Brown (Receptionist), Zara Lander (VN), Katy Kirkham (VN), Kathleen Gamble (VN), Grace Costall (Student VN), Kate Bodley (Small Animal Vet), Michael Lander (Small Animal Vet), Lucinda Ticehurst (Equine Vet).
Dechra Veterinary Products Brand Manager Craig Sankey said: "Hyperthyroidism is a common endocrine disorder that affects thyroid production in older cats. It’s a lifelong condition that requires careful understanding and management by both vets and owners.
"The video presentation aims to illustrate how, with flexibility and precision, you can take control of hyperthyroidism and restore the natural poise of your hyperthyroid patients."
To watch the film and enter the competition, visit: www.dechra.co.uk/3greatreasons.
Competition closes February 28th 2017.
The Brexit Barometer report draws on insights from 16 animal medicines companies and other stakeholders. 95% of those who contributed to the report, drawn up after NOAH’s Brexit event in May, said that they are optimistic about the future of animal health and welfare in the UK.
On the broader future of the industry, contributors to the report were more uncertain: 40% 'in the middle', 30% 'optimistic' and 25% 'pessimistic'. In contrast to animal welfare, contributors were most pessimistic about the future of trade and exports in relation to animal health.
While optimism about animal welfare remains high, NOAH says the animal medicines industry needs a continuation of its high standards of health and welfare to help tackle antibiotic resistance and to put the UK in a strong influencing position with our ability to trade. Six key measures in relation to health and welfare that Government needs to take to realise the opportunities were outlined in the report. They are:
• Maintaining the current Animal Welfare Acts and evolving them to secure the UK’s position from ‘Day 0’• Ensuring the industry is not disadvantaged by lack of veterinary medicines availability during the transition period and beyond, as new products come on the market• Ensuring that veterinary services are available in inner city and rural areas throughout the UK• Ensuring that a cross-border programme is in place to maintain cooperation between the UK and Europe• Recognising that animal diseases do not respect borders and to co-operate with our European neighbours to ensure that appropriate measures are in place to prevent and control disease outbreaks• Balancing first-class welfare standards with creating a level playing field for UK farmers and ensuring that British product does not become uncompetitive.
NOAH Chief Executive, Dawn Howard said: "While the Barometer showed that a large proportion of the industry was undecided when it comes to overall future of our sector, it tells us loudly and clearly that the sector sees a very clear opportunity for the UK to show leadership when it comes to animal health and welfare. What is vital now is that Government collaborates closely with industry and heeds its advice to realise this opportunity and leverage these high levels of optimism. We must not forget that veterinary medicines support the health and welfare of the UK’s livestock and pets and we stand ready to work with industry and Government to help make this happen."
BVA President Gudrun Ravetz said: "We have a unique selling point as 'UK PLC' around our high standards of animal welfare and food safety and these must be maintained in the wake of Brexit. This means tackling issues including veterinary involvement from farm to fork to underpin animal health, welfare and public health, through to guaranteeing working rights for vets and veterinary nurses. It is therefore vital that animal welfare is included in all trade negotiations."
The report can be read in full here: https://www.noah.co.uk/wp-content/uploads/2017/07/NOAH-Brexit-Barometer-Summer-17-6pp-A4-vf.pdf
The course helps veterinary practices manage their dispensaries with up-to-date information on medicines regulations. It covers the main aspects of dispensing including an overview and update on legislation, using the cascade and the storing and disposal of medicines. There will also be sessions covering controlled drugs, dispensing mishaps and what to expect from an inspection.
Tutors Pam Mosedale, Donal Murphy, Michael Stanford, Mike Jessop and John Millward will deliver lectures via webinars throughout the day, which ends with a live streamed interactive Q+A session.
The course is suitable for vets, vet nurses and other staff who deal with the dispensing of medicines and the pharmacy.
Attendees will have access to supporting resources for approximately two weeks after the course, including electronic course notes and lectures from the day and an active discussion forum.
The Association says course meets the RCVS practice standards veterinary hospital dispensing course requirements and is ideal for the new PSS Medicines Award CPD requirement.
It is also AMTRA accredited and carries 43 AMTRA CPD points.
Attendance for the day is compulsory and an attendance register will be taken for the Live Q&A session.
Course organiser Pam Mosedale said: “We are very excited to be able to deliver the BSAVA Dispensing Course online and still allow for interaction between speakers and delegates in the live session. With Practice Standards and VMD visits restarting, it is fantastic that we are still able to support practices in these difficult times by ensuring they are complying with the Veterinary Medicines Regulations.”
The course costs £150.00 (incl. VAT) for BSAVA members and £225.00 (incl. VAT) for non-members. To book visit https://www.bsava.com/Education/CPD/Event-Detail/dateId/2099
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Vétoquinol has announced plans to raise £10,000 for The Blue Cross pet charity through sales of Propalin, its fast acting treatment for incontinence in dogs.
From 1st July to 31st December this year, for every 100ml bottle of Propalin ordered, Vétoquinol will give 18p to The Blue Cross and 7p for every 30ml bottle.
To boost the amount raised for The Blue Cross, Vétoquinol is offering vets a free bottle of Propalin for every six bottles ordered of both the 100ml and 30ml sizes.
For example, if you order 18 100ml bottles of Propalin, you will receive 6 free bottles and The Blue Cross will receive £4.32.
Vanessa Rossiter, corporate fundraising officer for The Blue Cross said: “As a charity, The Blue Cross relies on donations to support our adoption centres and animal hospitals around the country. We are very grateful to Vétoquinol for their pledge to raise funds for the hundreds of needy animals in our care.”
According to Vétoquinol, Propalin is the UK’s best selling licensed veterinary treatment for urinary incontinence in the ***. It contains phenylpropanolamine hydrochloride, which acts to increase the tone in muscles that make up the urethal sphincter. It takes effect within 30 minutes of administration and, as a liquid, is highly palatable.
Genitrix has repackaged its palatable, fenbendazole-based treatment for internal parasites, with an easy dose syringe mechanism to allow its accurate administration to rabbits, ferrets, exotic birds and reptiles. To make life simpler for pet owners, it has also provided detailed dosing instructions for worming all the species for which it is indicated.
First launched in 2008, Lapizole is a broad spectrum oral-antiparasiticide for use in the prevention and treatment of infections caused by internal parasites of rabbits, birds, reptiles and ferrets, including Encephalitozoon cuniculi (E. cuniculi) in rabbits.
Genitrix' marketing director, Rob Watkins, said: "Lapizole proved itself as a highly effective treatment for E. cuniculi during its first year. Many of our customers have expressed the wish to use the treatment on a broader range of animals and in species groups for which highly accurate dosing and a syringe mechanism would be vital. We've taken their feedback on board and are delighted to be making Lapizole available to them with its new dispenser.
"The combination of efficacy, easy dosage and palatability make it an ideal product for the control of internal parasites in these species."
For more information, visit http://www.genitrix.co.uk/
The traditional method for detecting equine lameness is subjective, using expert visual evaluation of gait to identify the presence or absence and degree of asymmetries. The lame horse is described as having a disorder, defect or loss of function and this clinical diagnosis has associated welfare implications if the horse is still asked to perform.
The article explains how advanced computer technology is starting to change all this. Optic motion capture or the use of inertial measurement units (IMUs) is now enabling the detailed study and quantification of the horse’s gait; objective assessment against preset thresholds. The paper points out that while these digital systems can overcome the temporal and spatial limitations of the human eye they simply rely on one or a number of set gait parameters to decide about lameness and this can present obstacles.
Thresholds are forcibly based on a limited reference population, which doesn’t adequately reflect the millions of horses in the world. The individual environmental and mental conditions for each horse and its day-to-day gait variations are also not accounted for. On this basis to use the term ‘lame’ because a horse demonstrates a subtle gait alteration, causing it to fall below the threshold, could be inappropriate, particularly as it may not affect the horse’s welfare in any way.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "An important first step is for researchers and clinicians to start to discriminate clearly between 'asymmetry' and 'lameness' and not to use these as interchangeable terms when interpreting gait analysis data. Asymmetry is often, but not always, a hallmark of lameness, but is not a clinical term, whereas lameness is."
Elanco Companion Animal Health, maker of Comfortis, has launched a new campaign to raise awareness of the perennial problem of fleas, and the importance of regular treatment.
The campaign revolves around some new research which shows that while nearly half of dog owners1 allow their pets to swim at least once a month during the summer, over 45% of those questioned were unaware that if a dog is bathed or swims it may lose protection from spot-on flea treatments with only a sixth realising that the active ingredients in some spot-on insecticides can harm aquatic organisms2.
Gavin and Stacey actress Joanna Page, and RSPCA veterinary surgeon David Grant (pictured right) are being wheeled out to talk about the new research, both on the radio and on web TV.
In addition, Elanco says that a range of Comfortis support materials are available to help educate pet owners about fleas and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.
For further information please contact your local Elanco Companion Animal Health key account manager or email elancoah.uk@lilly.com.
References